Disparities in colorectal cancer in African-Americans vs Whites: before and after diagnosis.
There are differences between African-American and white patients with colorectal cancer, concerning their characteristics before and after diagnosis. Whites are more likely to adhere to screening guidelines. This is also the case among people with positive family history. Colorectal cancer is more frequent in Blacks. Studies have shown that that since 1985, colon cancer rates have dipped 20% to 25% for Whites, while rates have gone up for African-American men and stayed the same for African-American women. Overall, African-Americans are 38% to 43% more likely to die from colon cancer than are Whites. Furthermore, it seems that there is an African-American predominance in right-sited tumors. African Americans tend to be diagnosed at a later stage, to suffer from better differentiated tumors, and to have worse prognosis when compared with Whites. Moreover, less black patients receive adjuvant chemotherapy for resectable colorectal cancer or radiation therapy for rectal cancer. Caucasians seem to respond better to standard chemotherapy regimens than African-Americans. Concerning toxicity, it appears that patients of African-American descent are more likely to develop 5-FU toxicity than Whites, possibly because of their different dihydropyridine dehydrogenase status. Last but not least, screening surveillance seems to be higher among white than among black long-term colorectal cancer survivors. Socioeconomic and educational status account for most of these differences whereas little evidence exists for a genetic contribution in racial disparity. Understanding the nature of racial differences in colorectal cancer allows tailoring of screening and treatment interventions.
Dimou
Anastasios
A
Yale Cancer Center, Yale School of Medicine, New Haven, CT 06520, United States.
Syrigos
Kostas N
KN
Saif
Muhammad Wasif
MW
D001741:Black or African American; D015179:Colorectal Neoplasms / Q000175:diagnosis* / Q000208:ethnology* / Q000235:genetics* / Q000628:therapy; D004358:Drug Therapy; D005247:Feeding Behavior; D020022:Genetic Predisposition to Disease; D006801:Humans; D008403:Mass Screening / Q000523:psychology; D011379:Prognosis; D011788:Quality of Life; D011878:Radiotherapy; D044465:White People